Governance.
Optimi Health Corp. is a British Columbia corporation with securities listed on the Canadian Securities Exchange (CSE: OPTI), quoted on the OTCQX Best Market (OTCQX: OPTHF), and listed on the Frankfurt Exchange (FSE: 8BN).
- John James WilsonChairman of the BoardSince 2020
Mr. Wilson has served as Chairman of Optimi Health since May 2020. He is a Partner at Very Polite Agency, a global integrated communications and creative firm headquartered in Vancouver, and the founder of Reyal Performance, a men's performance skincare and supplements brand. His earlier experience includes leading the international expansion of the apparel brand Kit and Ace, where he oversaw retail, brand, and e-commerce growth worldwide.
- Dane StevensChief Executive Officer, Director & Co-FounderSince 2020
Mr. Stevens has served as Chief Executive Officer of Optimi Health since October 2024, and as a Director and Co-Founder since 2020. With almost two decades of experience in sourcing, manufacturing, and global distribution, he built vertically integrated businesses by managing every stage of the supply chain. Under his leadership the Company is producing GMP-certified MDMA and natural psilocybin and making them available through regulated treatment programs.
- Jacob SafarikChief Financial Officer & DirectorSince 2020
Mr. Safarik has served as Chief Financial Officer and Director of Optimi Health since 2020. A Chartered Professional Accountant, he brings more than 16 years of experience in accounting, project finance, business development, and quality assurance. At Optimi he is responsible for financial strategy, capital allocation, and disciplined cost management.
- Bryan SafarikChief Operating Officer & DirectorSince 2020
Mr. Safarik has served as Chief Operating Officer and Director of Optimi Health since 2020. With nearly two decades of senior management experience across fisheries, agriculture, and regulated industries, he previously served as Director of Marine Operations at Ocean Fisheries Ltd. prior to its sale to the Jim Pattison Group, and later co-founded a federally licensed cannabis production company. At Optimi he oversees production and operations with a focus on efficiency, quality, and scale.
- Jason MosberianIndependent DirectorSince 2022
Mr. Mosberian graduated from the Sauder School of Business and earned his CPA designation in 2011 after six years in audit in public practice. He currently serves as Senior Vice President and Partner at BFL Canada and has over a decade of experience providing tailored risk management and insurance solutions to clients in manufacturing, distribution, and life sciences.
- Dane StevensChief Executive OfficerSince 2024
CEO since October 2024, Director and Co-Founder since 2020. Nearly two decades of experience in sourcing, manufacturing, and global distribution, focused on building vertically integrated supply chains.
- Jacob SafarikChief Financial OfficerSince 2020
CFO and Director since 2020. Chartered Professional Accountant with 16+ years in accounting, project finance, business development, and QA across regulated sectors.
- Bryan SafarikChief Operating OfficerSince 2020
COO and Director since 2020. Nearly two decades of senior-management experience across regulated industries; former Director of Marine Operations at Ocean Fisheries Ltd. and co-founder of a federally licensed cannabis production company.
- Dr. Preston ChaseChief Science OfficerSince 2021
Research & Development chemist with 25+ years across multinational corporations and startups. BSc (University of Victoria), PhD (University of Calgary) in catalysis, synthesis, and analytical chemistry. 30+ peer-reviewed publications and multiple awarded and pending patents.
- Karina LahnakoskiDirector of Quality and Commercial StrategiesSince 2023
Quality and regulatory executive with 20+ years in pharmaceuticals, cannabis, and life sciences, specializing in GACP/GMP compliance, product commercialization, and global regulatory approvals. Former Partner in Deloitte's Risk Advisory practice and VP Quality & Regulatory at Cannabis Compliance Inc. BSc Biochemistry, MBA, PMP, ICD-certified director.
Audit Committee
Jason Mosberian (Chair), John James Wilson, Jacob SafarikOversees financial reporting, the external-auditor relationship with Davidson & Company LLP, and internal controls over financial reporting.
- Auditor
- Davidson & Company LLP
- Transfer agent
- Endeavor Trust Corporation
- +1 (604) 559-8880
The Company's Audit Committee Charter, Code of Business Conduct and Ethics, Insider Trading Policy, and Whistleblower Policy are referenced in the most recent Annual Information Form filed on SEDAR+. For copies, contact ir@optimi.net.